Status:
COMPLETED
Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Hepatitis B, Chronic
Eligibility:
All Genders
16+ years
Brief Summary
The purpose of this study is to support the clinical value of entecavir by assessing the relationship between viral load and histological improvement.
Detailed Description
Systematic review of prospective clinical trials
Eligibility Criteria
Inclusion
- Patients with CHB diagnosis and no co-infection with Hep A, Hep C, Hep D, or HIV
- Age 16 years or older
- No post-transplant patients
- RCT, non-randomized trials, prospective cohort studies, prospectively analyses case series published since 2003
- At least one arm of trial must include monotherapy with entecavir, lamivudine, tenofovir, adefovir, or telbivudine
- Study arms must include at least 10 patients
- Follow-up of at least 48 weeks
- Published results available in English language
Exclusion
- N/A
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01155427
Start Date
May 1 2009
End Date
April 1 2010
Last Update
July 1 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.